[go: up one dir, main page]

HN2009000503A - Procedimiento para la preparacion de halogenos de n-alquil-naltrexona. - Google Patents

Procedimiento para la preparacion de halogenos de n-alquil-naltrexona.

Info

Publication number
HN2009000503A
HN2009000503A HN2009000503A HN2009000503A HN2009000503A HN 2009000503 A HN2009000503 A HN 2009000503A HN 2009000503 A HN2009000503 A HN 2009000503A HN 2009000503 A HN2009000503 A HN 2009000503A HN 2009000503 A HN2009000503 A HN 2009000503A
Authority
HN
Honduras
Prior art keywords
carbonate
preparation
procedure
naltrexona
alquil
Prior art date
Application number
HN2009000503A
Other languages
English (en)
Inventor
Dlubala Alain
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HN2009000503A publication Critical patent/HN2009000503A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN NUEVO PROCEDIMIENTO DE PREPARACION DEL BROMURO DE N- METIL- NALTREXONA QUE COMPRENDE AL MENOS LAS ETAPAS QUE CONSISTE EN (1). HACER REACCIONA EL METILSULFATO DE N- METIL-NALTREXONA EN SOLUCION ACUOSA CON UN AGENTE ALCALINO ELEGIDO DEL GRUPO CONSTITUIDO POR CARBONATO DE SODI, CARBONATO DE POTASIO, CARBONATO DE CALCIO, CARBONATO DE MAGNESIO, CARBONATO DE CESIO, CARBONATO DE ESTRONCIO Y LAS MEZCLAS DE ESTOS, PARA UN PH MEDIO DE REACCION ACUOSO COMPRENDIDO ENTRE 7 Y 10 Y DESPUES (2) . HACER REACCIONAR EL PRODUCTO ASI OBTENIDO CON EL ACIDO BROMHIDRICO QUE SE AÑADE. PARA UN PH DEL MEDIO DE REACCION ACUOSO COMPRENDIDO ENTRE 0.5 Y 5 Y OBTENER ASI BROMURO DE N-METIL NALTREXONA.
HN2009000503A 2006-09-21 2009-03-18 Procedimiento para la preparacion de halogenos de n-alquil-naltrexona. HN2009000503A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0608286A FR2906252B1 (fr) 2006-09-21 2006-09-21 Procede de preparation d'halogenures de n-aklyl naltrexone

Publications (1)

Publication Number Publication Date
HN2009000503A true HN2009000503A (es) 2011-03-02

Family

ID=38016779

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2009000503A HN2009000503A (es) 2006-09-21 2009-03-18 Procedimiento para la preparacion de halogenos de n-alquil-naltrexona.

Country Status (35)

Country Link
US (2) US7645880B2 (es)
EP (1) EP2069362B1 (es)
JP (1) JP5214615B2 (es)
KR (1) KR101434693B1 (es)
CN (2) CN101516892B (es)
AR (1) AR062918A1 (es)
AU (1) AU2007298855B2 (es)
BR (1) BRPI0718440A2 (es)
CA (1) CA2663509C (es)
CL (1) CL2007002711A1 (es)
CO (1) CO6170362A2 (es)
CR (1) CR10660A (es)
DO (1) DOP2011000307A (es)
EA (1) EA015426B1 (es)
ES (1) ES2531093T3 (es)
FR (1) FR2906252B1 (es)
GT (1) GT200900060A (es)
HN (1) HN2009000503A (es)
IL (1) IL197402A (es)
JO (1) JO3023B1 (es)
MA (1) MA30793B1 (es)
ME (1) MEP10509A (es)
MX (1) MX2009003084A (es)
MY (1) MY148094A (es)
NI (1) NI200900035A (es)
NO (1) NO20091561L (es)
NZ (1) NZ575417A (es)
PE (1) PE20080867A1 (es)
SV (1) SV2009003192A (es)
TN (1) TN2009000080A1 (es)
TW (1) TWI465451B (es)
UA (1) UA96957C2 (es)
UY (1) UY30599A1 (es)
WO (1) WO2008034973A1 (es)
ZA (1) ZA200901846B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801979A (zh) 2007-03-29 2010-08-11 普罗热尼奇制药公司 (r)-n-溴化甲基纳曲酮的晶体形式及其用途
WO2008138383A1 (de) * 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
WO2009009292A2 (en) * 2007-07-11 2009-01-15 Mallinckrodt Inc. Crystalline forms of naltrexone methobromide
EP2019105A1 (en) * 2007-07-19 2009-01-28 Siegfried Ltd. Process for the preparation of quaternary n-alkyl morphine or morphinane alkaloid derivatives
ES2566559T3 (es) * 2008-09-30 2016-04-13 Mallinckrodt Llc Procesos para la alquilación de grupos amino secundarios de derivados de morfinano
US8563727B2 (en) * 2009-02-23 2013-10-22 Mallinckrodt Llc (+)-morphinanium N-oxides and processes for their production
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
EP2398807A1 (en) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8436174B2 (en) * 2009-02-23 2013-05-07 Mallinckrodt Llc (+)-morphinanium quaternary salts and processes for their production
CN102459275A (zh) 2009-04-24 2012-05-16 布鲁克大学 制备吗啡烷和吗啡酮化合物的方法
WO2011009020A2 (en) 2009-07-16 2011-01-20 Mallinckrodt Inc. Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
CN101845047B (zh) * 2009-12-31 2011-12-07 南京臣功制药有限公司 一种溴甲基纳曲酮的制备方法
US8580963B2 (en) 2010-11-05 2013-11-12 H. Lundbeck A/S Method for the manufacturing of naltrexone
JO3209B1 (ar) * 2010-11-05 2018-03-08 H Lundbeck As طريقة لتصنيع نالتريكسون
WO2012059103A1 (en) * 2010-11-05 2012-05-10 H. Lundbeck A/S Method for the manufacturing of naltrexone
WO2012138888A1 (en) 2011-04-05 2012-10-11 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
JP2014526467A (ja) 2011-09-08 2014-10-06 マリンクロッド エルエルシー 中間体の単離なしでのアルカロイドの調製
CN103172640A (zh) * 2011-12-22 2013-06-26 天津康鸿医药科技发展有限公司 一种(r)-n-溴甲基纳曲酮的制备方法以及纳曲酮衍生物
WO2013164383A1 (en) 2012-05-03 2013-11-07 H. Lundbeck A/S Method for the manufacturing of naltrexone
CN105985348B (zh) * 2015-02-12 2019-02-01 正大天晴药业集团股份有限公司 一种溴甲基纳曲酮的制备方法
CN106317064B (zh) * 2015-06-30 2018-06-19 北大方正集团有限公司 溴甲纳曲酮的制备方法
KR102201609B1 (ko) * 2019-04-19 2021-01-12 연성정밀화학(주) 날데메딘의 제조방법
CN111777617B (zh) * 2020-07-10 2025-06-06 华润三九医药股份有限公司 一种溴甲纳曲酮的精制方法
EP4225312A1 (en) 2020-10-06 2023-08-16 Scilex Holding Company Oral delayed burst formulation of low-dose naltrexone or naloxone used for treating fibromyalgia and long covid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
ATE444295T1 (de) * 2002-11-08 2009-10-15 Mallinckrodt Inc Verfahren zur herstellung von quaternäre n-alkyl morphinan alkaloid salzen
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
JP5214615B2 (ja) 2013-06-19
UY30599A1 (es) 2008-05-02
CA2663509A1 (fr) 2008-03-27
CO6170362A2 (es) 2010-06-18
HK1135389A1 (en) 2010-06-04
US8288547B2 (en) 2012-10-16
BRPI0718440A2 (pt) 2013-11-19
NI200900035A (es) 2010-01-26
CR10660A (es) 2009-06-24
TN2009000080A1 (en) 2010-08-19
SV2009003192A (es) 2009-10-27
MY148094A (en) 2013-02-28
EP2069362B1 (fr) 2014-07-09
DOP2011000307A (es) 2011-10-31
CL2007002711A1 (es) 2008-04-18
FR2906252B1 (fr) 2008-11-28
WO2008034973A1 (fr) 2008-03-27
AU2007298855B2 (en) 2012-09-13
EA015426B1 (ru) 2011-08-30
MA30793B1 (fr) 2009-10-01
KR20090057031A (ko) 2009-06-03
UA96957C2 (ru) 2011-12-26
TW200821314A (en) 2008-05-16
CN101516892B (zh) 2012-06-20
KR101434693B1 (ko) 2014-08-27
NO20091561L (no) 2009-06-16
ES2531093T3 (es) 2015-03-10
ME00613B (me) 2011-12-20
MX2009003084A (es) 2009-04-02
TWI465451B (zh) 2014-12-21
IL197402A (en) 2012-12-31
PE20080867A1 (es) 2008-08-22
MEP10509A (en) 2011-12-20
US7645880B2 (en) 2010-01-12
JP2010504308A (ja) 2010-02-12
JO3023B1 (ar) 2016-09-05
US20080214817A1 (en) 2008-09-04
GT200900060A (es) 2011-01-04
CA2663509C (fr) 2014-03-18
ZA200901846B (en) 2010-07-28
AR062918A1 (es) 2008-12-17
EP2069362A1 (fr) 2009-06-17
US20100145051A1 (en) 2010-06-10
EA200970307A1 (ru) 2009-12-30
FR2906252A1 (fr) 2008-03-28
NZ575417A (en) 2011-09-30
CN101516892A (zh) 2009-08-26
AU2007298855A1 (en) 2008-03-27
IL197402A0 (en) 2009-12-24
CN102225939A (zh) 2011-10-26

Similar Documents

Publication Publication Date Title
HN2009000503A (es) Procedimiento para la preparacion de halogenos de n-alquil-naltrexona.
ES2555989T3 (es) Procedimiento para la síntesis del ácido 2,5-furanodicarboxílico
CL2012001646A1 (es) Metodo de secuestro de dioxido de carbono producido por una fuente que comprende: a) obtener una sal de hidroxido en una mezcla acuosa, b) mezclar sal de hidroxido con dioxido de carbono para formar primera sal de carbonato en primera mezcla, c) clorar mineral de silicato desde grupo-2 del acido clorhidrico d) mezclar sal de cloruro con sal de carbonato y e) separar dicha sal de carbonato.
PT1881957E (pt) Processo para a produção de sais tri (metal alcalinos) de metil glicina-n,n-diácido etanoico de baixo teor de produtos secundários
BR112012027444A2 (pt) bloco cáustico altamente concentrado para lavagem de louças
WO2009001777A1 (ja) 二酸化塩素の製造方法、及び該方法に用いる二酸化塩素製造用アルカリ組成物
TW200633951A (en) Method for reducing cyclohexenone content of a cyclohexenone-containing organic mixture
EP1690832A4 (en) CALCIUM HYDROXIDE, RESIN COMPOSITION CONTAINING THE SAME AND ARTICLE FORM
BRPI0608102A2 (pt) método para formar um sal de metal alcalino
MX2013003581A (es) Proceso para producir granulos que comprende una o mas sales de agentes complejas.
CR9424A (es) Ibuprofeno solubilizado
WO2008105141A1 (ja) 塩化カルボニルの中和処理方法
RU2011118200A (ru) Способ получения диоксида хлора
DOP2009000041A (es) Procedimiento de preparacion de halogenuros de n-alquil-naltrexona
GB2481756A (en) Carbon dioxide sequestration using aqueous hydroxide solution of alkali and alkaline earth metals
MX2008008634A (es) Proceso continuo para la purificacion de salmuera.
WO2007129184A3 (en) An improved process for the preparation of phenytoin sodium
RU2012144162A (ru) Способ получения продукта для регенерации воздуха
BRPI0700896A (pt) processo de fabricação de um agente redutor quìmico a base de so2 e um agente redutor quìmico a base de so2
TW200745009A (en) Process for producing dilute perglutaric acid solution
CL2008002657A1 (es) Proceso para la obtencion de sulfato de sodio e hidroxido de magnesio a partir de mezcla que contiene sales de solubles de na y mg que incluye acondicionar, crsitalizar na2so4 con una solucion rica en na2so4, precipiatar mg(oh)2 con un alcali, regenerar alcali y recircular alcali y solucion rica en na2so4 a sus respectiva etapas.
RU2008115190A (ru) Способ получения ингибитора кислотной коррозии
UA85565C2 (ru) Способ выделения винилхлорида и винилиденхлорида из хлорорганических отходов щелочным дегидрохлорированием
RU2007108391A (ru) Способ получения водорода